Third party FCPA compliance for life sciences companies
As your life sciences company leverages resources abroad and expands globally, compliance with the Foreign Corrupt Practices Act (FCPA) becomes a business imperative for your organization. Noncompliance with these strict laws, whether through your immediate business or via your third-party relationships, could be costly from a reputational standpoint as well as affect your bottom line and future profitability. How do you get to the core of what’s needed from your business to mitigate these regulatory risks?
Watch this video to learn more about some of the strategies that can uncover FCPA noncompliance with new or existing third parties, like leveraging a scoring matrix, focused vetting efforts as well as specialized due diligence. For additional information on this topic, check out the infographic below.
Click to enlarge the infographic and learn more.
YOU MAY ALSO BE INTERESTED IN
Learn considerations for life sciences companies when it comes to FCPA compliance and third party risk management.
RSM’s life sciences industry insider shares key insights and benefits of conducting a third-party contract compliance audit.
Third parties provide a vital business partnership for growing life sciences companies, but there are risks to consider.